Honolulu, HINCT06672302Now EnrollingIRB Ready

Breast Neoplasm Clinical Trial in Honolulu, HI

Access cutting-edge breast neoplasm treatment through this clinical trial at a research site in Honolulu. Study-provided care at no cost to qualified participants.

Sponsored by EXoPERT

Quick Self-Assessment

See if you qualify for this Honolulu location

Preparing your pre-screening questions…

Expert Care in Honolulu

Access breast neoplasm specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related breast neoplasm treatment provided free

Apply for This Honolulu Location

Check if you qualify for this breast neoplasm clinical trial in Honolulu, HI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Honolulu

    Convenient for HI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Honolulu site if eligible
  4. 4Begin participation

About This Breast Neoplasm Study in Honolulu

EXoPERT has developed a liquid biopsy-based in vitro diagnostic medical device that can diagnose cancer through blood. The in vitro diagnostic medical device for this clinical performance trial is a test device that applies a technology that measures Raman spectroscopic signals of extracellular vesicles in the blood and classifies high-risk and low-risk patients for breast cancer through artificial intelligence analysis. The test device used in this clinical performance trial is expected to assist in the differential diagnosis of high-risk and low-risk breast cancer patients by developing a software algorithm for an in vitro diagnostic medical device for auxiliary diagnosis that classifies high-risk and low-risk breast cancer patients and confirming the clinical efficacy and safety of the device through this clinical performance trial.

Sponsor: EXoPERT

Who Can Participate

Inclusion Criteria

(Breast malignant nodule group)
Korean nationality
Voluntary written consent to participate in this clinical performance trial study
Confirmed breast cancer through imaging/pathologic diagnostic tests
Those who have been diagnosed with breast cancer at a stage prior to treatment and surgery, and who agree to participate in this study and are able to provide blood samples.
Those whose lesions have been confirmed by conventional examination (breast ultrasound or mammography) and who fall into BI-RADS categories 4,5,6 and have undergone biopsy or are scheduled to undergo biopsy within 2 weeks.
Those who meet the following demographic conditions A. Adult female, 40 years of age or older
Those who can provide the following clinical information A. Age and biological sex B. Whether or not they have dense breasts C. Occupational information D. Pathological tumor size, Clinical tumor size, Pathological TNM staging, Clinical TNM staging, tumor location, breast cancer histology findings (breast cancer subtype) E. Family history and past history of cancer F. Breast-related diseases G. Chronic disease history Inclusion Criteria(Breast benign nodule group)
Korean nationality
Voluntary written consent to participate in this clinical performance trial study
Diagnosed with breast nodules through imaging/pathologic diagnostic tests
Those who have been diagnosed with breast nodules and have agreed to participate in this study and are able to provide blood samples at a stage prior to treatment and surgery.
Those whose lesions have been confirmed by conventional examination (breast ultrasound or mammography) and fall into BI-RADS categories 4,5,6 and have undergone biopsy or are scheduled for biopsy within 2 weeks
Those who meet the following demographic conditions A. Adult female, 40 years of age or older
Those who can provide the following clinical information A. Age and biological sex B. Whether or not they have dense breasts C. Occupational information D. Diagnosis, nodule size, and number of nodules E. Family history and past history of cancer F. Breast-related diseases G. Chronic disease history

Exclusion Criteria

Those who have been diagnosed with cancer (malignant tumor) of any type within 5 years of the date of consent and have undergone appropriate chemotherapy/radiation treatment or surgery.
Those who are confirmed to have developed breast cancer due to metastasis from malignant tumors other than breast cancer
Pregnant women
Participation in a drug-related clinical trial within 3 months of the date of the informed consent form

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Honolulu?

Yes, this clinical trial (NCT06672302) has an active research site in Honolulu, HI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Breast Neoplasm Treatment Options in Honolulu, HI

If you're searching for breast neoplasm treatment options in Honolulu, HI, this clinical trial (NCT06672302) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Honolulu research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast neoplasm specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all breast neoplasm clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Honolulu, HI

See all breast cancer clinical trials recruiting in Honolulu — not just this study.

Browse Breast Cancer Trials in Honolulu →

Ready to Join in Honolulu?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Honolulu, HI